1. Home
  2. FGEN vs XBP Comparison

FGEN vs XBP Comparison

Compare FGEN & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • XBP
  • Stock Information
  • Founded
  • FGEN 1993
  • XBP N/A
  • Country
  • FGEN United States
  • XBP United Kingdom
  • Employees
  • FGEN N/A
  • XBP N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • XBP Business Services
  • Sector
  • FGEN Health Care
  • XBP Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • XBP Nasdaq
  • Market Cap
  • FGEN 34.5M
  • XBP 36.2M
  • IPO Year
  • FGEN 2014
  • XBP N/A
  • Fundamental
  • Price
  • FGEN $0.36
  • XBP $1.01
  • Analyst Decision
  • FGEN
  • XBP
  • Analyst Count
  • FGEN 0
  • XBP 0
  • Target Price
  • FGEN N/A
  • XBP N/A
  • AVG Volume (30 Days)
  • FGEN 898.0K
  • XBP 31.7K
  • Earning Date
  • FGEN 11-12-2024
  • XBP 11-12-2024
  • Dividend Yield
  • FGEN N/A
  • XBP N/A
  • EPS Growth
  • FGEN N/A
  • XBP N/A
  • EPS
  • FGEN N/A
  • XBP N/A
  • Revenue
  • FGEN $180,015,000.00
  • XBP $157,146,000.00
  • Revenue This Year
  • FGEN $19.67
  • XBP N/A
  • Revenue Next Year
  • FGEN N/A
  • XBP N/A
  • P/E Ratio
  • FGEN N/A
  • XBP N/A
  • Revenue Growth
  • FGEN 16.15
  • XBP N/A
  • 52 Week Low
  • FGEN $0.18
  • XBP $0.84
  • 52 Week High
  • FGEN $2.93
  • XBP $6.58
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 45.24
  • XBP 40.18
  • Support Level
  • FGEN $0.31
  • XBP $1.03
  • Resistance Level
  • FGEN $0.37
  • XBP $1.16
  • Average True Range (ATR)
  • FGEN 0.03
  • XBP 0.10
  • MACD
  • FGEN -0.01
  • XBP -0.02
  • Stochastic Oscillator
  • FGEN 25.66
  • XBP 3.41

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About XBP XBP Europe Holdings Inc.

XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.

Share on Social Networks: